title: Characterization of urinary metabolites of testosterone, methyltestosterone, mibolerone and boldebone in greyhound dogs.
abstract: Androgenic steroids are used in female greyhound dogs to prevent the onset of estrus; moreover, these steroids also have potent anabolic activity. As anabolic steroids increase muscle mass and aggression in animals, the excessive use of these agents in racing greyhounds gives an unfair performance advantage to treated dogs. The biotransformation of most anabolic steroids has not been determined in greyhound dogs. The objective of the present study was to identify the urinary metabolites of testosterone, methyltestosterone, mibolerone, and boldenone in greyhound dogs. These steroids were administered orally (1 mg/kg) to either male or female greyhound dogs and urine samples were collected pre-administration and at 2, 4, 8, 12, 24, 72, and 96 h post-administration. Urine extracts were analyzed by high-performance liquid chromatography/mass spectrometry (HPLC/MS) to identify major metabolites and to determine their urinary excretion profiles. Major urinary metabolites, primarily glucuronide, conjugated and free, were detected for the selected steroids. Sulfate conjugation did not appear to be a major pathway for steroid metabolism and excretion in the greyhound dog. Phase I biotransformation was also evaluated using greyhound dog liver microsomes from untreated dogs. The identification of several in vivo steroid metabolites generated in this study will be useful in detecting these steroids in urine samples submitted for drug screening.
authors: Department of Pharmaceutical Sciences, University of Connecticut, Storrs 06269, USA.
authors: T M
authors: TM
authors: Williams
authors: A J
authors: AJ
authors: Kind
authors: W G
authors: WG
authors: Hyde
authors: D W
authors: DW
authors: Hill
mesh_terms: D000284:Administration, Oral; D045930:Anabolic Agents / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine; D000818:Animals; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D005260:Female; D012739:Gonadal Steroid Hormones / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine; D008297:Male; D008777:Methyltestosterone / Q000378:metabolism* / Q000652:urine; D008862:Microsomes, Liver / Q000378:metabolism*; D009277:Nandrolone / Q000031:analogs & derivatives* / Q000378:metabolism / Q000652:urine; D013739:Testosterone / Q000031:analogs & derivatives* / Q000378:metabolism* / Q000493:pharmacokinetics / Q000652:urine
chemical_list: D045930:Anabolic Agents; D012739:Gonadal Steroid Hormones; D013739:Testosterone; C013915:boldenone; D009277:Nandrolone; C100075:mibolerone; D008777:Methyltestosterone